SG50507A1 - Indole derivates as 5-ht1a and/or 5-ht2 ligands - Google Patents

Indole derivates as 5-ht1a and/or 5-ht2 ligands

Info

Publication number
SG50507A1
SG50507A1 SG1996002949A SG1996002949A SG50507A1 SG 50507 A1 SG50507 A1 SG 50507A1 SG 1996002949 A SG1996002949 A SG 1996002949A SG 1996002949 A SG1996002949 A SG 1996002949A SG 50507 A1 SG50507 A1 SG 50507A1
Authority
SG
Singapore
Prior art keywords
ht1a
ligands
derivates
indole
indole derivates
Prior art date
Application number
SG1996002949A
Other languages
English (en)
Inventor
Quintero Myrna Gil
Vincenzo Martino
Franco Borsini
Carlo Maria Pellegrini
Marco Turconi
Ettore Giraldo
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of SG50507A1 publication Critical patent/SG50507A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
SG1996002949A 1993-04-08 1994-03-31 Indole derivates as 5-ht1a and/or 5-ht2 ligands SG50507A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Publications (1)

Publication Number Publication Date
SG50507A1 true SG50507A1 (en) 1998-07-20

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002949A SG50507A1 (en) 1993-04-08 1994-03-31 Indole derivates as 5-ht1a and/or 5-ht2 ligands

Country Status (20)

Country Link
US (1) US5834493A (cs)
EP (1) EP0694033A1 (cs)
JP (1) JPH08508738A (cs)
CN (1) CN1124960A (cs)
AU (1) AU684276B2 (cs)
BG (1) BG100040A (cs)
BR (1) BR9406206A (cs)
CA (1) CA2160020A1 (cs)
CZ (1) CZ283398B6 (cs)
FI (1) FI954734L (cs)
HU (1) HUT74090A (cs)
IL (1) IL109234A (cs)
IT (1) IT1271352B (cs)
NO (1) NO953967L (cs)
NZ (1) NZ265055A (cs)
PL (1) PL310995A1 (cs)
SG (1) SG50507A1 (cs)
SK (1) SK119795A3 (cs)
WO (1) WO1994024125A1 (cs)
ZA (1) ZA942383B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
WO1998051685A1 (en) * 1997-05-09 1998-11-19 H. Lundbeck A/S Method of manufacturing sertindole
JP2002509149A (ja) 1998-01-14 2002-03-26 ザ ユーエイビー リサーチ ファウンデイション 細菌nadシンテターゼ酵素の阻害剤の合成およびスクリーニング方法、その化合物、ならびに細菌nadシンテターゼ酵素の阻害剤を用いる細菌および微生物感染の治療方法
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
JP2002510676A (ja) * 1998-04-08 2002-04-09 アメリカン・ホーム・プロダクツ・コーポレイション うつ病治療用のn−アリールオキシエチルアミン誘導体
JP2002513018A (ja) * 1998-04-29 2002-05-08 アメリカン・ホーム・プロダクツ・コーポレイション セロトニン作動薬
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MXPA03005433A (es) 2000-12-22 2003-09-10 Wyeth Corp Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
KR101868165B1 (ko) * 2010-04-22 2018-07-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
WO2013155504A1 (en) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc. Novel methods
WO2014145192A1 (en) 2013-03-15 2014-09-18 Intra-Cellular Therapies, Inc. Organic compounds
CN105939712A (zh) 2013-12-03 2016-09-14 细胞内治疗公司 新方法
US9745300B2 (en) 2014-04-04 2017-08-29 Intra-Cellular Therapies, Inc. Organic compounds
KR20170012210A (ko) 2014-04-04 2017-02-02 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
EP3331530A4 (en) * 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
KR20240170975A (ko) 2016-01-26 2024-12-05 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
ES2879888T3 (es) 2016-03-25 2021-11-23 Intra Cellular Therapies Inc Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central
EP3436083A4 (en) 2016-03-28 2019-11-27 Intra-Cellular Therapies, Inc. NOVEL COMPOSITIONS AND METHOD
EP3525763B1 (en) 2016-10-12 2025-03-05 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
IL268970B2 (en) 2017-03-24 2023-12-01 Intra Cellular Therapies Inc Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes
CA3071119A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment or prophylaxis of central nervous system disorders
CN111093664B (zh) 2017-07-26 2023-06-02 细胞内治疗公司 有机化合物
WO2019183341A1 (en) 2018-03-23 2019-09-26 Intra-Cellular Therapies, Inc. Organic compounds
EP3801527B1 (en) 2018-06-08 2025-02-19 Intra-Cellular Therapies, Inc. Fused gamma-carbolines for acute treatment of anxiety or depression
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
KR20210052472A (ko) 2018-08-31 2021-05-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CA3108553A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
CN114072150A (zh) 2019-07-07 2022-02-18 细胞内治疗公司 新方法
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 N,n’−ジ置換アミド誘導体
TW226019B (cs) * 1992-03-23 1994-07-01 Sankyo Co

Also Published As

Publication number Publication date
NZ265055A (en) 1996-09-25
BR9406206A (pt) 1996-02-06
EP0694033A1 (en) 1996-01-31
BG100040A (bg) 1996-03-29
AU6538294A (en) 1994-11-08
IT1271352B (it) 1997-05-27
HU9502913D0 (en) 1995-11-28
CN1124960A (zh) 1996-06-19
ITMI930699A1 (it) 1994-10-08
CZ283398B6 (cs) 1998-04-15
FI954734A0 (fi) 1995-10-05
ZA942383B (en) 1995-10-09
WO1994024125A1 (en) 1994-10-27
NO953967L (no) 1995-12-05
CA2160020A1 (en) 1994-10-27
FI954734A7 (fi) 1995-10-05
NO953967D0 (no) 1995-10-05
IL109234A (en) 1998-04-05
JPH08508738A (ja) 1996-09-17
SK119795A3 (en) 1996-04-03
ITMI930699A0 (it) 1993-04-08
IL109234A0 (en) 1994-07-31
AU684276B2 (en) 1997-12-11
CZ260295A3 (en) 1996-01-17
FI954734L (fi) 1995-10-05
HUT74090A (en) 1996-11-28
US5834493A (en) 1998-11-10
PL310995A1 (en) 1996-01-22

Similar Documents

Publication Publication Date Title
SG50507A1 (en) Indole derivates as 5-ht1a and/or 5-ht2 ligands
HU9402983D0 (en) Indol derivatives
ZA941483B (en) Indole derivatives
SG49013A1 (en) Indole derivatives
GB9308695D0 (en) Peptidyl derivatives
GB9319297D0 (en) Indole derivatives
GB9326332D0 (en) Indole derivatives
AP9400633A0 (en) Indole derivatives
GB9413772D0 (en) 5-HT1A ligands
HU9402534D0 (en) New naphtoxazine derivatives
GB9322269D0 (en) Seasoning can structure
GB2274282B (en) Piperazine-and piperidine-isoxazole derivatives
ZA946220B (en) Azoxycyanobenzodioxane derivates
GB9304440D0 (en) 2-acyloxycephem derivatives
GB9302577D0 (en) Indole derivatives
GB9310092D0 (en) Indole derivatives
GB9311613D0 (en) Thienylthiazole derivatives
PL300513A1 (en) New kind of cooked ham in the block form
GB9324433D0 (en) Indoles
GB9308360D0 (en) Indoles
ZA943683B (en) Indoles
GB9307080D0 (en) Indole derivatives
GB9309148D0 (en) Indole derivatives
GB9319299D0 (en) Indole derivatives
GB9303475D0 (en) Fractal patterns